(Q26851652)

language of work or name

1 reference

May 2015

1 reference

1 reference

479-480

1 reference

PubMed

page(s)

221-33

1 reference

Cell culture-adaptive NS3 mutations required for the robust replication of genome-length hepatitis C virus RNA.

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

New horizons in hepatitis C antiviral therapy with direct-acting antivirals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Assembly of infectious hepatitis C virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Targeting ribosome assembly on the HCV RNA using a small RNA molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

A chimeric mouse model to study immunopathogenesis of HCV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Generation of a humanized mouse model with both human immune system and liver cells to model hepatitis C virus infection and liver immunopathogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Efficient initiation of HCV RNA replication in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Engraftment of severe combined immune deficient/beige mice with bovine foetal lymphoid tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Extrahepatic manifestations of chronic hepatitis C virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Ultrastructural analysis of hepatitis C virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Development of a robust luciferase reporter 1b/2a hepatitis C virus (HCV) for characterization of early stage HCV life cycle inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Replication of Hepatitis C Virus (HCV) RNA in Mouse Embryonic Fibroblasts: Protein Kinase R (PKR)-Dependent and PKR-Independent Mechanisms for Controlling HCV RNA Replication and Mediating Interferon Activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Broadly neutralizing antibodies abrogate established hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Completion of the entire hepatitis C virus life cycle in genetically humanized mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

A genetically humanized mouse model for hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Diverse CD81 Proteins Support Hepatitis C Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Hepatitis: Brain endothelial cells support HCV entry and replication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Analysis of hepatitis C virus core/NS5A protein co-localization using novel cell culture systems expressing core-NS2 and NS5A of genotypes 1-7.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Sequence requirements for the development of a chimeric HCV replicon system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Miravirsen (SPC3649) can inhibit the biogenesis of miR-122.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Adapted J6/JFH1-based Hepatitis C virus recombinants with genotype-specific NS4A show similar efficacies against lead protease inhibitors, alpha interferon, and a putative NS4A inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Differential efficacy of protease inhibitors against HCV genotypes 2a, 3a, 5a, and 6a NS3/4A protease recombinant viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Dominant negative effect of wild-type NS5A on NS5A-adapted subgenomic hepatitis C virus RNA replicon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Identification of PTC725, an orally bioavailable small molecule that selectively targets the hepatitis C Virus NS4B protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

The reconstituted 'humanized liver' in TK-NOG mice is mature and functional.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Development of Intergenotypic Chimeric Replicons To Determine the Broad-Spectrum Antiviral Activities of Hepatitis C Virus Polymerase Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Scavenger receptor class B type I mediates cell entry of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Factors affecting hepatocyte isolation, engraftment, and replication in an in vivo model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

A Cell-Based Model of HCV-Negative-Strand RNA Replication Utilizing a Chimeric Hepatitis C Virus/Reporter RNA Template

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Nonstructural Protein Precursor NS4A/B from Hepatitis C Virus Alters Function and Ultrastructure of Host Secretory Apparatus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Hepatitis C Virus E2 Envelope Glycoprotein Core Structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Hepatitis C Virus Replication in Transfected and Serum-Infected Cultured Human Fetal Hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Roles for T and NK cells in the innate immune response to Shigella flexneri

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Replication of a novel subgenomic HCV genotype 1a replicon expressing a puromycin resistance gene in Huh-7 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Characterization of hepatitis C virus NS3 modifications in the context of replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Complete replication of hepatitis C virus in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Direct visualization of hepatitis C virus-infected Huh7.5 cells with a high titre of infectious chimeric JFH1-EGFP reporter virus in three-dimensional Matrigel cell cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

A cell culture adapted HCV JFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Hepatitis C virus (HCV) interaction with astrocytes: nonproductive infection and induction of IL-18.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Introduction of NS5A mutations enables subgenomic HCV replicon derived from chimpanzee-infectious HC-J4 isolate to replicate efficiently in Huh-7 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Treating viral hepatitis C: efficacy, side effects, and complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Identification of transferrin receptor 1 as a hepatitis C virus entry factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Hepatitis C virus replication in mice with chimeric human livers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Global distribution and prevalence of hepatitis C virus genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

In vivo evaluation of the cross-genotype neutralizing activity of polyclonal antibodies against hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Characterization of truncated forms of hepatitis C virus glycoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Molecular and immunological significance of chimpanzee major histocompatibility complex haplotypes for hepatitis C virus immune response and vaccination studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Suppression of viral RNA binding and the assembly of infectious hepatitis C virus particles in vitro by cyclophilin inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Depression and neuroticism in patients with chronic hepatitis C: correlation with peripheral blood mononuclear cells activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Synthesis and anti-HCV activity evaluation of anilinoquinoline derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Binding of hepatitis C virus to CD81

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Inhibition of the interaction between NS3 protease and HCV IRES with a small peptide: a novel therapeutic strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Complete reconstitution of mouse liver with xenogeneic hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Mutational analysis of the hepatitis C virus E1 glycoprotein in retroviral pseudoparticles and cell-culture-derived H77/JFH1 chimeric infectious virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Production of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Three-dimensional Huh7 cell culture system for the study of Hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-α.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Modeling hepatitis C virus infection using human induced pluripotent stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Development and characterization of a transient-replication assay for the genotype 2a hepatitis C virus subgenomic replicon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Trans-complementation of HCV replication by non-structural protein 5A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Detection of hepatitis C viral sequences in non-A, non-B hepatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Modulation of replication efficacy of the hepatitis C virus replicon Con1 by site-directed mutagenesis of an NS4B aminoterminal basic leucine zipper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Blocking Hepatitis C Virus Infection with Recombinant Form of Envelope Protein 2 Ectodomain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Extensive double humanization of both liver and hematopoiesis in FRGN mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Hepatitis C virus genotype 5a subgenomic replicons for evaluation of direct-acting antiviral agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Transmission of hepatitis C virus infection to tree shrews

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Efficient infection of tree shrew (Tupaia belangeri) with hepatitis C virus grown in cell culture or from patient plasma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Robust and persistent replication of the genotype 6a hepatitis C virus replicon in cell culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014

Robust hepatitis C virus infection in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2015.03.014